Responsiveness to Dalfampridine-ER Treatment Among Multiple Sclerosis Patients

NCT01399957 · clinicaltrials.gov ↗
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Mount Sinai Rehabilitation Hospital

Collaborators